These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36621893)

  • 1. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.
    Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM
    Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes of Clostridioides difficile infection in inpatient liver transplant population.
    Amjad W; Qureshi W; Malik A; Singh R; Jafri SM
    Transpl Infect Dis; 2022 Feb; 24(1):e13750. PubMed ID: 34695277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission.
    Wijarnpreecha K; Aby ES; Kim D; Ungprasert P; Cheungpasitporn W; Thongprayoon C; Lukens FJ; Harnois DM; Kröner PT
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):894-898. PubMed ID: 32541243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of Clostridioides difficile infection on outcomes among kidney transplant recipients.
    Iqbal H; Patel J; Singh I; Kohli I; Thind N; Dhiman M; Sohal A; Yang J
    Am J Infect Control; 2024 Jul; 52(7):795-800. PubMed ID: 38395312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
    Donnelly JP; Wang HE; Locke JE; Mannon RB; Safford MM; Baddley JW
    Am J Transplant; 2015 Nov; 15(11):2970-7. PubMed ID: 26484839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
    Ortiz-Balbuena J; Royuela A; Calderón-Parra J; Martínez-Ruiz R; Asensio-Vegas Á; Múñez E; Valencia-Alijo Á; Gutiérrez-Rojas Á; Ussetti P; Cuervas-Mons V; Segovia-Cubero J; Portolés-Pérez J; Ramos-Martínez A
    Transplant Proc; 2021 Dec; 53(10):2826-2832. PubMed ID: 34772488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readmission, healthcare consumption, and mortality in Clostridioides difficile infection hospitalizations: a nationwide cohort study.
    Sharma S; Weissman S; Walradt T; Aziz M; Vohra I; Acharya A; Sotiriadis J; Feuerstein JD; Tabibian JH
    Int J Colorectal Dis; 2021 Dec; 36(12):2629-2635. PubMed ID: 34363511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
    Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
    Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of Clostridioides difficile on COVID-19 hospitalizations in the USA.
    Sohal A; Chaudhry H; Singla P; Sharma R; Kohli I; Dukovic D; Prajapati D
    J Gastroenterol Hepatol; 2023 Apr; 38(4):590-597. PubMed ID: 36662626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients.
    Kortt NC; Santhakumar C; Davis RJ; Strasser SI; McCaughan GW; Liu K; Majumdar A
    Transpl Infect Dis; 2022 Feb; 24(1):e13758. PubMed ID: 34762768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
    Barbar R; Hayden R; Sun Y; Tang L; Hakim H
    Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
    Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
    mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.